Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Forecast Highlighting Expansion And Competitive Dynamics
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Expected Market Value Outlook For The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Through 2030?
The artificial intelligence (AI)-powered rare disease diagnosis market has experienced significant expansion in recent years. This market is expected to increase from $1.99 billion in 2025 to $2.56 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 28.9%. The historical growth of this market is linked to several factors: increasing diagnostic complexities for rare conditions, the wider availability of genetic testing, higher investments in rare disease research, the expanding application of data analytics in healthcare, and the early integration of AI-driven diagnostic instruments.
The market for artificial intelligence (AI)-powered rare disease diagnosis is projected to experience substantial expansion in the coming years. This market is anticipated to reach $7.08 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 28.9%. This projected growth is driven by several factors, including a greater emphasis on personalized medicine, the increasing implementation of AI-assisted clinical decision support systems, the broader integration of genomic sequencing, heightened investment in rare disease screening initiatives, and a rising need for improved diagnostic efficiency. Key trends during this period involve the expanding application of AI for pattern recognition in rare conditions, a surge in the adoption of genomic data analytics platforms, the enhanced integration of multi-modal patient data, the proliferation of cloud-based diagnostic solutions, and a heightened commitment to achieving early and precise diagnoses.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28139&type=smp
Which Major Factors Are Contributing To The Development Of The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?
The increasing occurrence of autoimmune disorders is anticipated to propel the expansion of the artificial intelligence (AI)-powered rare disease diagnosis market moving forward. These conditions involve the immune system mistakenly attacking the body’s own healthy cells and tissues, resulting in inflammation and damage. The growing prevalence of autoimmune disorders is due to a rising number of individuals experiencing immune system dysfunctions, leading to an elevated demand for prompt diagnosis, advanced treatments, and continuous monitoring to manage symptoms effectively. Artificial intelligence (AI)-powered rare disease diagnosis supports the management of autoimmune disorders by swiftly identifying complex conditions, facilitating personalized treatment decisions, and enhancing overall diagnostic precision. For instance, in January 2025, reports from the Mayo Clinic, a US-based nonprofit academic medical center, indicated that approximately 15 million people are estimated to have one or more of 105 autoimmune diseases. Consequently, the expanding prevalence of autoimmune disorders is a key driver for the growth of the artificial intelligence (AI)-powered rare disease diagnosis market.
How Is The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Structured Across Different Market Segments?
The artificial intelligence (AI)-powered rare disease diagnosis market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Technology: Machine Learning, Deep Learning, Natural Language Processing, Computer Vision, Other Technologies
3) By Deployment Mode: Cloud-Based, On-Premises
4) By Diagnosis Type: Genetic Disorders, Autoimmune Disorders, Metabolic Disorders, Infectious Diseases, Other Diagnosis Types
5) By End-User: Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Other End-Users
Subsegments:
1) By Software: Clinical Decision Support, Data Analytics Platforms, Genomic Interpretation Tools, Machine Learning Algorithms, Diagnostic Reporting Software
2) By Hardware: Sequencing Instruments, Imaging Devices, Laboratory Equipment, Computational Servers, Diagnostic Sensors
3) By Services: Consulting Services, Implementation And Integration, Training And Support, Data Management Services, Maintenance And Upgrades
What Trends Are Affecting The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Dynamics?
Leading companies in the artificial intelligence (AI)-powered rare disease diagnosis market are concentrating on creating innovative technology, such as unified genomic diagnostics solutions, to boost diagnostic accuracy, reduce processing time, and provide more extensive understanding of complex genetic disorders. A unified genomic diagnostics solution functions as an integrated system that merges whole-genome sequencing with artificial intelligence (AI)-driven analysis to deliver comprehensive genetic insights. For instance, in October 2023, Oxford Nanopore Technologies plc, a UK-based biotechnology company, and Fabric Genomics Inc., a US-based artificial intelligence (AI)-based company, launched an integrated whole-genome sequencing solution designed to accelerate rare disease diagnosis by combining rapid sequencing with AI-driven variant interpretation for more precise and actionable clinical insights. This launch integrates real-time nanopore sequencing with artificial intelligence (AI)-powered genomic analysis to swiftly identify rare genetic variants. It provides comprehensive, actionable insights to clinicians, improving diagnostic speed and accuracy for pediatric care.
Who Are The Major Companies Operating In The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?
Major companies operating in the artificial intelligence (AI)-powered rare disease diagnosis market are Ambry Genetics Corporation, MedGenome Inc., Sophia Genetics SA, Variantyx Inc., Atropos Health Inc., Congenica Ltd., Saventic Care Sp. z o.o., Rapid Innovation LLC, Centogene N.V., Impilo AB, ThinkGenetic Inc., ClairLabs Ltd., 3billion Inc., OpenEvidence Inc., GenomeUp S.R.L., Mendel.ai Inc., RareSum GmbH, DeepRare AI Solutions, Zebra-Llama Project
Access The Complete Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Report:
Which Region Commands The Largest Share Of The Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market?
North America was the largest region in the artificial intelligence (AI)-powered rare disease diagnosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered rare disease diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=28139&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Powered Rare Disease Diagnosis Market 2026, By The Business Research Company
Artificial Intelligence In The Diagnostic Global Market Report 2026
Ai In Medical Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report
Artificial Intelligence In Cancer Diagnostics Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
